Trade Summary

3 days ago, Rothblatt Martine A, serving as CHAIRPERSON, CEO at United Therapeutics Corp (UTHR), sold 9,500 shares at $499.42 per share, for a total transaction value of $4,744,467.00. Following this transaction, Rothblatt Martine A now holds 639,489 shares of UTHR.

This sale represents a 1.00% decrease in Rothblatt Martine A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.